Pure Global AI
Manufacturer profile

LINE.

IndonesiaUnited States8 products registered
VerifiedKemenkes (Ministry of Health) · official registry
8
Total Products
8
Product Names
1
Product Classes
1
Risk Classes
Regulatory footprint
Search LINE. across other regulatory registries
ThailandEuropean UnionColombiaSouth KoreaCanadaEcuador
Risk classification breakdown
Distribution of products across risk classes
Kelas Resiko : B8100.0% of total
Product class portfolio
Products organized by product class
Kelas : 2
CELL-DYN 22 Plus Control, CELL-DYN 22 Plus Calibrator, CELL-DYN 29 Plus Control (with retic), ALINITY h-series Hemcal, ABBOTT CELL-DYN 18 Plus Calibrator ... and 3 more products in this class
8 Products
Recent registrations (8 most recent)
Most recently registered products with Ministry of Health
CELL-DYN 22 Plus Control
Dec 13, 2024
Class
Kelas : 2
Risk Class
Kelas Resiko : B
CELL-DYN 22 Plus Calibrator
Dec 13, 2024
Class
Kelas : 2
Risk Class
Kelas Resiko : B
CELL-DYN 29 Plus Control (with retic)
Nov 20, 2024
Class
Kelas : 2
Risk Class
Kelas Resiko : B
ALINITY h-series Hemcal
Aug 8, 2024
Class
Kelas : 2
Risk Class
Kelas Resiko : B
ABBOTT CELL-DYN 18 Plus Calibrator
Dec 26, 2022
Class
Kelas : 2
Risk Class
Kelas Resiko : B
CELL-DYN Retic Plus Control
Dec 8, 2022
Class
Kelas : 2
Risk Class
Kelas Resiko : B
CELL DYN 26 Plus Control
May 5, 2021
Class
Kelas : 2
Risk Class
Kelas Resiko : B
CELL-DYN 18 Plus Control
Apr 9, 2021
Class
Kelas : 2
Risk Class
Kelas Resiko : B
About this profile

LINE. from United States is a medical device manufacturer with 8 registered products in the Indonesia Ministry of Health database through Pure Global AI's free platform. The company produces 8 unique product types across 1 product class.

This page provides comprehensive manufacturer intelligence including complete product portfolio, risk class distribution, and product class analysis. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify manufacturers, analyze portfolios, and discover partnership opportunities efficiently.